Trending...
- SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in LifeStance Health Group, Inc. with Losses of $100,000 to Contact the Firm
- INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Marqeta, Inc. with Losses of $100,000 to Contact the Firm
- INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Centessa Pharmaceuticals plc with Losses of $100,000 to Contact the Firm
SAN FRANCISCO , July 1, 2022 /PRNewswire/ -- Telegraph Hill Partners (THP), a venture capital and growth equity firm dedicated to building life science and healthcare technology businesses, announced that it has closed on THP V, a new $525 million investment fund. The fund will make investments in innovative companies that are commercializing advanced technologies in areas including life science tools, reagents, specialty chemistries, medical technology, medical devices, diagnostics, healthcare IT, healthcare services, agriculture and animal health. THP V will be managed by a team close to major life science and medical innovation hubs, and includes Matt Mackowski, Deval Lashkari, Tom Raffin, Jeanette Welsh, Alex Efron, Kate Cilio and Linda Gregoire in San Francisco; Paul Grossman in San Diego; Rob Hart in Miami; Alex Herzick and Rob Capone in Research Triangle Park; and Gary Curtis in New Haven.
More on The Californer
"We are grateful to our limited partners for their continued support for our team and investment philosophy of building long-term value through company development," stated Matt Mackowski, Chairman of THP. "We particularly thank the management and staff of our current and prior portfolio companies for their exceptional performance which enabled the formation of THP V, our largest fund since we formed Telegraph Hill Partners 21 years ago."
Consistent with its previous funds, THP V will invest in innovative companies across the lifecycle from startup to fully scaled. Investments will be structured to effectively address the capital needs of each company and its founders, and will include startup and growth capital, existing shareholder liquidity events, acquisitions/buyouts and corporate divestitures.
About Telegraph Hill Partners
Telegraph Hill Partners, founded in 2001 and headquartered in San Francisco, CA, invests in life science, medical technology and healthcare companies. For more information, please see www.telegraphhillpartners.com.
SOURCE Telegraph Hill Partners
More on The Californer
- Gilead to Acquire Remaining Worldwide Rights of Trodelvy®
- The Law Offices of Frank R. Cruz Announces Investigation of Polished.com Inc. (POL) on Behalf of Investors
- California: Governor Newsom Signs Legislation 8.15.22
- Annabella in July at North Coast Repertory Theatre
- The Law Offices of Frank R. Cruz Continues Its Investigation of Argo Group International Holdings, Ltd. (ARGO) on Behalf of Investors
"We are grateful to our limited partners for their continued support for our team and investment philosophy of building long-term value through company development," stated Matt Mackowski, Chairman of THP. "We particularly thank the management and staff of our current and prior portfolio companies for their exceptional performance which enabled the formation of THP V, our largest fund since we formed Telegraph Hill Partners 21 years ago."
Consistent with its previous funds, THP V will invest in innovative companies across the lifecycle from startup to fully scaled. Investments will be structured to effectively address the capital needs of each company and its founders, and will include startup and growth capital, existing shareholder liquidity events, acquisitions/buyouts and corporate divestitures.
About Telegraph Hill Partners
Telegraph Hill Partners, founded in 2001 and headquartered in San Francisco, CA, invests in life science, medical technology and healthcare companies. For more information, please see www.telegraphhillpartners.com.
SOURCE Telegraph Hill Partners
Filed Under: Business
0 Comments
Latest on The Californer
- Wood Underwear® FW22 Introduces New Styles in Lounge
- Nutanix Announces New Virtual "Nutanix Essentials" Event
- Jacobs Center's Business Accelerator Program Celebrates its Sixth Cohort with Virtual Pitch Competition in Partnership with Union Bank
- Loxperts Inc. launches the first-ever on-demand freelancer marketplace dedicated to localization experts
- Energous Corporation Names Two New Directors
- AI-designed camera only records objects of interest while being blind to others
- Distinguishing New Dishes With 'Man Of The Hour's'- 'Entree'
- Last Chance for Animals, Animal Liberation Wave Undercover Investigation Unveils More Atrocities in South Korean Dog Meat Trade
- Kelp, the best source of all minerals, Dr. Abhay Kumar Pati, D.Sc
- Can Picking Up the Phone Save Lives & Provide Long COVID Cures? UCSF & Partners' Study To Find Out
- HutchinsonReport Documentary Productions Premiers Gripping New Film Driving Death While Black
- AHF LA Times Ad: 'City Hall: Save the Clark Hotel'
- THE LOOKS FROM BEYONCÉ'S RENAISSANCE ALBUM IS A SARTORIAL CELEBRATION OF FASHION FOR THE AGES
- INVESTOR NOTICE: Investors in Coinbase Global, Inc. with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – COIN
- California: Governor Newsom's Ambitious Climate Proposals Presented to Legislature
- Cymbiotika Announces Partnership with Medical Advisor Dr. Pejman Taghavi
- ArborWorks LLC Announces the Promotion of Mr. Clint Stephens to Vice President of Operations, Southeastern Region
- What They're Saying: State and Local Leaders Across California Applaud Selection of Antonio Villaraigosa as Infrastructure Advisor
- Agent Timothy Braue Awarded Prestigious "Premier Luxury Marketing Consultant" Certification
- INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Centessa Pharmaceuticals plc with Losses of $100,000 to Contact the Firm